ArticleCancer2021
Reply to The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data.
Rowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, Ross L Prentice
Abstract readLetterComment
In one paragraphArticle in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
- Comment on
- Comment on
- Comment on
5 · Who and what moneyAuthors and funding
4 authors.
Rowan T ChlebowskiLundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California.ORCID 0000-0002-4212-6184 Aaron K AragakiDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Garnet L AndersonDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Ross L PrenticeDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Funding
Women's Health Initiative Clinical Coordinating CenterN01WH22110 · WH · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRENTICE, ROSS L · 2007 to 2010
$22.5MWOMENS HEALTH INITIATIVE-N01WH22110N01WH022110 · WH · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSS, PRENTICE · 1992 to 2006
$1.2MRAS AND IGF 1 SIGNALING PATHWAYS IN CARDIAC GROWTHK08HL003211 · NHLBI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI HUNTER, JOHN J · 1994 to 1998
–STUDIES OF THE ALLOIMMUNE RESPONSE TO F VIII COAGULANTR01HL032115 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI REISNER, HOWARD M · 1985 to 1986
–the National Heart, Lung and Blood Institute, National Institutes of Health 24152the National Heart, Lung and Blood Institute, National Institutes of Health 32100-2the National Heart, Lung and Blood Institute, National Institutes of Health 32105-6the National Heart, Lung and Blood Institute, National Institutes of Health 32108-9the National Heart, Lung and Blood Institute, National Institutes of Health 3211the National Heart, Lung and Blood Institute, National Institutes of Health 32111-13the National Heart, Lung and Blood Institute, National Institutes of Health 32115the National Heart, Lung and Blood Institute, National Institutes of Health 32118-32119the National Heart, Lung and Blood Institute, National Institutes of Health 32122the National Heart, Lung and Blood Institute, National Institutes of Health 42107-26the National Heart, Lung and Blood Institute, National Institutes of Health 42129-32the National Heart, Lung and Blood Institute, National Institutes of Health 44221WHI NIH HHS N01WH22110
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Hormone Replacement TherapyWomen's HealthFemaleHumans
What Socratic holds
Textmetadata
Read underepoch 390